Trial results of Zika vaccine Sanofi dropped show promise

CHICAGO (Reuters) – A Zika vaccine Sanofi SA dropped in September under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S. researchers reported on Monday.


Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *